12/25/2023 0 Comments Triumeq copay card 2018![]() ![]() The number of drugs in use decreased over time in the intervention group (β = − 0.054 per month p < 0.05).Ĭonclusion: A clinical medication review focused on personal goals, improves the self-rated quality of life of older patients with polypharmacy and reduces the number of health-related complaints with impact on daily life, while the number of drugs in use decreases.ĭisclosure of Interest: None Declared. The self-rated HR-QoL (EQ-VAS) increased over 6 months in the intervention group (β = 1.7 p < 0.01) compared to control group and the number of complaints with impact on daily life decreased in the intervention group (β = − 0.17 p = 0.029). Results: Over 6 months, the utility measured with EQ-5D-5L remained equal between both groups (β = 0.0011 p = 0.90) and the total number of complaints, irrespective of severity, did not change (β = − 0.14 p = 0.12). Effects were analysed with linear mixed model analysis. Also, the number of drugs in use were measured. Complaints were defined as number of complaints independent of severity and number of complaints with impact on daily life (VAS-score ≥ 5 and influence on daily life on 5-point Likert scale: moderate-severe). Main outcome measures: Health-related quality of life (HR-QoL) was measured with EQ-5D-5L (utility) and EQ-VAS. 629 persons aged 70 years and over using seven or more chronic drugs were randomly assigned to usual care (n = 314 control group) or to receive a CMR (n = 315 intervention group) and were measured after 3 and 6 months. Setting and method: The DREAMeR study was a randomized controlled trial performed in 35 community pharmacies located throughout the Netherlands. Therefore, the objective of this study is to investigate the effects of a CMR, focused on personal goals, on quality of life and health-related complaints in older patients with polypharmacy. To improve quality of life a CMR could be more focused on health-related complaints and wishes of older persons. There is little evidence for effects on clinical outcomes. Bouvy 1,2 1SIR Institute for Pharmacy Practice and Policy, Leiden, 2Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht, 3Department of Public Health and Primary care, 4Department of Gerontology and Geriatrics, Leiden University Medical Center (LUMC), Leiden, Netherlandsīackground and objective: A clinical medication review (CMR) can reduce drug-related problems (DRPs). CP-PC001: Effects of drug use reconsidered in the elderly using goal attainment scales during medication review: DREAMeR results of a randomized controlled trial S. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |